Filter posts

South Africa National Policy on Intellectual Property: Inconsistent with Biotech Development Goals

BIO submitted comments this week to the government of South Africa on their proposed “Draft …

The "Designer Baby" Patent: Why the Patent System Should Not Regulate Science

23andMe received criticism this week from a few bioethicists in the journal Genetics in Medicine, …

New Bill Calls for No WTO-Plus Benefits for Countries that Violate IP

A new Bill in the U.S. House of Representatives seeks to remove WTO-plus trade benefits …

India’s IP Policy: India’s Lead Biotech Innovator Expresses Concern

Kiran Mazumdar-Shaw, chairperson and managing director of India’s largest biotechnology company Biocon, expressed concern with …

Patent Trolls and Patent Litigation: The GAO Weighs In

Patent troll litigation alarmist were likely disappointed by the GAO report.  While the public discourse …

What a Patent is Not

‘Patent trolls.’  ‘Patients over patents.’  ‘Do Not Patent My Genes.’  ‘Patents ate my baby.’  Ok, …

Fresenius v. Baxter: BIO files Amicus Brief in Federal Circuit

The Biotechnology Industry Organization filed an amicus brief at the Federal Circuit in the case …

Bayh-Dole and Technology Transfer Continue to Deliver

The Association of University Technology Managers released the 2012 AUTM U.S. Licensing Activity Survey Highlights …

Patent Docs Highlights the BIO IPDx Symposium

Patent Docs recently highlighted McDonnell Boehnen Hulbert & Berghoff’s (MBHB) panel at BIO’s IP and …

BIO IP & Diagnostics Symposium

BIO’s IP & Diagnostics Symposium (BIO IPDX) will review the current patent law landscape and …